VentiRx Pharmaceuticals Secures $19,352,414 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=af62708f-b9b1-4a55-bbfa-5a96d79044ad
Date
9/23/2014
Company Name
VentiRx Pharmaceuticals
Mailing Address
1191 Second Avenue Seattle, WA 98101 USA
Company Description
VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
Website
http://www.ventirx.com
Transaction Type
Venture Equity
Transaction Amount
$19,352,414
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor